PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports positive results of NV-387 in protecting lungs from damage in influenza virus infection. NV-387 treatment showed reduced lung infiltration, cell death, mucus load, and increased survival -
-
-
PRESS RELEASE
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. reports positive results of broad-spectrum antiviral drug NV-387 in animal models, showing sustained antiviral effect with extended flat blood concentration profile upon oral administration -
-
-
PRESS RELEASE
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza
